Exelixis Inc at Cantor Fitzgerald Global Healthcare Conference (Virtual) Transcript
Hey, everybody. It's Alethia Young. I cover  large-cap, small, mid-cap biotech here at Cantor. Very happy to have Exelixis here with me to round out day 2, saving the best for last.
We have Dr. Mike Morrissey, who is Director, President and CEO of Exelixis. And we'll be doing a fireside chat for 30 minutes and a lot to work through. But Mike can (inaudible) going first, which is 9ER. Surprise, surprise.
Questions & Answers
But it's obviously a huge focus. And just -- I want you to just frame what you can for us around some of the new analysis that we'll get and how to think about some of those results relative to the competition?
Yes. For sure. Well, thanks again for having us. We've had a great day meeting with investors at your
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
